Sarcomatoid carcinoma after radiation treatment of prostatic adenocarcinoma

Annals of Diagnostic Pathology

Volumn 12, Issue 2, 2008, Pages 142-145

  Huan, Youming ^a   Idrees, Muhammad ^a   Gribetz, Michael E ^a   Unger, Pamela D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

p53; p63; Postradiation sarcoma; Prostate; Sarcomatoid carcinoma

Indexed keywords

BICALUTAMIDE; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; KI 67 ANTIGEN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53; RADIOACTIVE IODINE; VIMENTIN;

AGED; ANTIGEN DETECTION; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CELL NUCLEUS; EXTERNAL BEAM RADIOTHERAPY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; RADIATION CARCINOGENESIS; SARCOMATOID CARCINOMA; SPINDLE CELL; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TUMOR CELL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOSARCOMA; FATAL OUTCOME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, RADIATION-INDUCED; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 39749110084     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2006.08.008     Document Type: Article

References (15)

1. Lauwers G.Y., Schevchuk M., Armenakas N., and Reuter V.E. Carcinosarcoma of the prostate. Am J Surg Pathol 17 4 (1993) 342-349
2. Young R.H., Srigley J.R., Amin M.B., Albright T.M., and Cubiua A.L. Tumors of the prostate gland, seminal vesicles, male urethra and penis. In: Rosai J. (Ed). Atlas of tumor pathology, third series (1998), Armed Forces Institute of Pathology, Washington, DC 238
3. Lopez-Beltran A., Pacelli A., Rothenberg H.J., Wollan P.C., Zincke H., and Blute M.L. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol 159 5 (1998) 1497-1503
4. Kohn H.I., and Fry R.J.M. Radiation carcinogenesis. N Engl J Med 310 (1984) 504-511
5. Canfield S.E., Gans T.H., Unger P., and Hall S.J. Postradiation prostatic sarcoma: de novo carcinogenesis or dedifferentiation of prostatic adenocarcinoma?. Tech Urol 7 4 (2001) 294-295
6. Neugut A.I., Ahsan H., Robinson E., and Ennis R.D. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 79 8 (1997) 1600-1604
7. Cahan W.G., Woodard H.Q., Higinbotham N.L., Stewart F.W., and Coley B.L. Sarcoma arising in irradiated bone: report of 11 cases. Cancer 82 1 (1998) 8-34
8. Shannon R.L., Ro J.Y., Grignon D.J., et al. Sarcomatoid carcinoma of the prostate. A clinicopathologic study of 12 patients. Cancer 69 11 (1992) 2676-2682
9. Dundore P.A., Cheville J.C., Nascimento A.G., Farrow G.M., and Bostwick D.G. Carcinosarcoma of the prostate. Report of 21 cases. Cancer 76 6 (1995) 1035-1042
10. Locke J.R., Soloway M.S., Evans J., and Murphy W.M. Osteogenic differentiation associated with x-ray therapy for adenocarcinoma of the prostatic gland. Am J Clin Pathol 85 3 (1986) 375-378
11. Delahunt B., Eble J.N., Nacey J.N., and Grebe S.K. Sarcomatoid carcinoma of the prostate: progression from adenocarcinoma is associated with p53 over-expression. Anticancer Res 19 5B (1999) 4279-4283
12. Smith N.D., Rubenstein J.N., Eggener S.E., and Kozlowski J.M. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol 169 4 (2003) 1219-1228 [review]
13. Parsons J.K., Gage W.R., Nelson W.G., and De Marzo A.M. P63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Urology 58 4 (2001) 619-624
14. Nylander K., Vojtesek B., Nenutil R., et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 198 4 (2002) 417-427
15. Kaufmann O., Fietze E., Mengs J., and Dietel M. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116 6 (2001) 823-830